Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) released its eighth annual Value-based Care (VBC) Report, revealing significant benefits for Medicare Advantage members under VBC agreements. Members saved 245,000 hospital days, with a 7% reduction in hospital admissions and a 12% drop in ER visits. The report highlights a 13.4% reduction in total medical costs, equating to $3.1 billion savings, and increased telemedicine use, especially during COVID-19. The findings underscore VBC's effectiveness in improving patient outcomes and adapting care delivery amidst pandemic challenges.
Humana Inc. (NYSE: HUM) and Mays Business School at Texas A&M University announced the winners of the 2021 Humana-Mays Healthcare Analytics Case Competition. The competition engaged over 750 master's students from 75 universities, awarding a total of $80,000 in prizes. The first-place team from Georgia Tech received $50,000 for their innovative analysis addressing vaccine hesitancy among vulnerable populations. Humana aims to leverage the insights from this competition to enhance healthcare delivery and address health equity challenges.
Summary not available.
Humana Inc. (NYSE: HUM) has added the veteran population to its Bold Goal communities, aimed at enhancing health through social determinants. This integration leverages partnerships with Veteran Service Organizations like VFW and DAV, focusing on food insecurity, social isolation, and health equity. Humana introduced the Humana Honor Medicare Advantage plan tailored for veterans, enhancing their healthcare options. The company continues to invest in hiring veterans to improve service delivery and health outcomes, reinforcing its commitment to the veteran community.
CarePlus Health Plans, a subsidiary of Humana (HUM), has achieved a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for its Medicare Advantage HMO plan in Florida. This marks the fifth time the company has received this rating, underscoring its commitment to quality healthcare and customer service. CarePlus has doubled its membership over the last six years, now serving approximately 200,000 members. The company emphasizes collaboration with healthcare providers to enhance member experiences and health outcomes.
Summary not available.
Humana Inc. (HUM) reported 3Q21 earnings of $11.84 per diluted share (GAAP) and $4.83 (Adjusted), with year-to-date EPS at $22.77 (GAAP) and $19.40 (Adjusted). The company revised its FY 2021 EPS guidance down to $23.67 (GAAP) and $20.50 (Adjusted), citing COVID-19 impacts. Despite this, individual Medicare Advantage membership is expected to grow by 11% year-over-year, with 97% of members in 4-Star plans or above. Revenues for 3Q21 reached $20.7 billion compared to $20.1 billion in 3Q20, driven by strong core operations.
Humana Inc. has launched the new CareBreeze (HMO C-SNP) plan for Medicare beneficiaries facing chronic lung disorders, supplementing its existing CareComplete (HMO C-SNP) plan aimed at those with diabetes and heart disease. The CareBreeze plan is available during the Medicare enrollment period from Oct. 15 to Dec. 7, 2021 with coverage starting on Jan. 1, 2022. With 14% of Floridians impacted by chronic lung conditions, this initiative aims to enhance treatment quality and affordability, supported by a 5-star CMS rating for the upcoming plan year.
Humana Inc. (NYSE: HUM) declared a cash dividend of $0.70 per share, scheduled for payment on January 28, 2022. This payment will benefit stockholders on record as of the close of business on December 31, 2021. Humana's commitment to improving health care delivery and well-being for its members reinforces its strategic focus on integrated care, which aims to reduce costs while enhancing quality of life for diverse populations, including Medicare beneficiaries and military service personnel.
Humana Inc. (NYSE: HUM) has launched a new initiative through its Medicaid business, Humana Healthy Horizons, to deploy two mobile clinics in Louisiana, funded with a commitment of $400,000. The clinics, operated in partnership with Ochsner Health, will provide essential health services to underserved populations, including screenings, immunizations, and telehealth access, operating up to six days a week. This initiative addresses health inequities exacerbated by COVID-19 and recent natural disasters. The mobile clinics are expected to be fully operational later this month.